Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Steris Plc shares valued at $477,581 were sold by Zangerle John Adam on Jun 13 ’25. At $241.45 per share, Zangerle John Adam sold 1,978 shares. The insider’s holdings dropped to 33,760 shares worth approximately $7.98 million following the completion of this transaction.
Also, Zangerle John Adam purchased 1,978 shares, netting a total of over 477,580 in proceeds.
Before that, Carestio Daniel A had sold 17,626 shares from its account. In a trade valued at $4,275,338, the President and CEO traded Steris Plc shares for $242.56 each. Upon closing the transaction, the insider’s holdings decreased to 17,626 shares, worth approximately $12.14 million.
As published in their initiating research note from Jefferies on May 29, 2025, Steris Plc [STE] has been a Hold and the price target has been revised to $263. Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in late October. Earlier on May 30, 2023, Morgan Stanley initiated its rating. Their recommendation was “an Equal-weight” for STE stock.
Analyzing STE Stock Performance
On last trading session,, Steris Plc [NYSE: STE] plunged -0.36% to $236.23. During the last five days, there has been a drop of approximately -1.87%. Over the course of the year, Steris Plc shares have jumped approximately 14.92%. Shares of the company reached a 52-week high of $252.79 on 05/19/25 and a 52-week low of $200.98 on 01/03/25.
Support And Resistance Levels for Steris Plc (STE)
According to the 24-hour chart, there is a support level at 235.34, which, if violated, would cause prices to drop to 234.46. In the upper region, resistance lies at 237.69. The next price resistance is at 239.16. RSI (Relative Strength Index) is 43.58 on the 14-day chart, showing neutral technical sentiment.
Which companies own the most shares of Steris Plc (STE)?
In terms of Steris Plc share price expectations, FactSet research, analysts set an average price target of 260 in the next 12 months, up nearly 9.67% from the previous closing price of $237.08. Analysts anticipate Steris Plc stock to reach 265 by 2025, with the lowest price target being 245. In spite of this, 4 analysts ranked Steris Plc stock as Buy at the end of 2025. On April 14, 2023, Piper Sandler assigned a price target of “a Neutral” to the stock and downgraded coverage with a $197.
